Results 31 to 40 of about 1,264,620 (412)

Treatment planning with a 2.5 MV photon beam for radiation therapy

Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Purpose The shallow depth of maximum dose and higher dose fall‐off gradient of a 2.5 MV beam along the central axis that is available for imaging on linear accelerators is investigated for treatment of shallow tumors and sparing the organs at risk (OARs) beyond it.
Navid Khaledi, Chris Hayes, Louise Belshaw, Mark Grattan, Rao Khan, James L. Gräfe   +5 more
wiley   +1 more source

A vision transformer-based framework for knowledge transfer from multi-modal to mono-modal lymphoma subtyping models [PDF]

, 2023
Determining lymphoma subtypes is a crucial step for better patient treatment targeting to potentially increase their survival chances. In this context, the existing gold standard diagnosis method, which relies on gene expression technology, is highly expensive and time-consuming, making it less accessibility.
arxiv   +1 more source

Laryngeal lymphoma : the high and low grades of rare lymphoma involvement sites [PDF]

, 2014
The larynx is an extremely rare site of involvement by lymphomatous disease.We present two cases of isolated laryngeal high-grade and another low-grade lymphoma, together with a literature review of laryngeal lymphoma management.peer ...
Azzopardi, Charles Paul, Betts, Alexandra, Camilleri, David J., Degaetano, James, Farrugia, Eric, Gatt, Alexander, Magri, Claude, Refalo, Nicholas   +7 more
core   +3 more sources

A predictive model for aggressive non-Hodgkin's lymphoma.

New England Journal of Medicine, 1993
BACKGROUND Although many patients with intermediate-grade or high-grade (aggressive) non-Hodgkin's lymphoma are cured by combination chemotherapy, the remainder are not cured and ultimately die of their disease.
M. Shipp, D. Harrington, James R. Anderson, J. Armitage, G. Bonadonna, G. Brittinger, F. Cabanillas, G. Canellos, B. Coiffier, J. Connors, R. A. Cowan, D. Crowther, S. Dahlberg, M. Engelhard, R. Fisher, C. Gisselbrecht, S. Horning, É. Lepage, T. Lister, J. H. Meerwaldt, E. Montserrat, N. Nissen, M. Oken, B. Peterson, C. Tondini, W. Velasquez, B. Yeap   +26 more
semanticscholar   +1 more source

Incidental finding of lymphoma after septoplasty. [PDF]

, 2016
IntroductionSeptoplasty, or surgical correction of the deviated septum, is an elective, routinely performed rhinologic procedure to address nasal airway obstruction.
Bhuta, Sunita M, Kedeshian, Paul A, Kuan, Edward C, Palma Diaz, Miguel Fernando, Suh, Jeffrey D, Tajudeen, Bobby A   +5 more
core   +2 more sources

Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma

New England Journal of Medicine, 2018
Background Diffuse large B‐cell lymphomas (DLBCLs) are phenotypically and genetically heterogeneous. Gene‐expression profiling has identified subgroups of DLBCL (activated B‐cell–like [ABC], germinal‐center B‐cell–like [GCB], and unclassified) according ...
R. Schmitz, George W. Wright, D. Huang, Calvin A. Johnson, J. Phelan, James Q Wang, S. Roulland, M. Kasbekar, R. Young, A. Shaffer, D. Hodson, Wenming Xiao, Xin Yu, Yandan Yang, Hong Zhao, Weihong Xu, Xuelu Liu, Bin Zhou, Wei Du, W. Chan, E. Jaffe, R. Gascoyne, J. Connors, E. Campo, A. López-Guillermo, A. Rosenwald, G. Ott, J. Delabie, L. Rimsza, Kevin Tay Kuang Wei, A. Zelenetz, J. Leonard, N. Bartlett, Bao Tran, Jyoti Shetty, Yongmei Zhao, D. Soppet, S. Pittaluga, W. Wilson, L. Staudt   +39 more
semanticscholar   +1 more source

Diffuse large B-cell lymphoma

Definitions, 2020
Understanding Lymphoma and Chronic Lymphocytic Leukemia (CLL) is published by the Lymphoma Research Foundation for the purpose of informing and educating readers.
MD S. Dabaja, MD Ranjana Advani, MD David C. Hodgson, MD Sughosh Dhakal, MD Christopher R. Flowers, Chul, MD S. Ha, Mph Bradford S Hoppe MD, MD Nancy P. Mendenhall, MD Monika L. Metzger, MD PhD John P. Plastaras, MD Kenneth B. Roberts, MD Ronald Shapiro, Sonali, MD M. Smith, MD Stephanie A. Terezakis, M. P. Karen M. Winkfield, MD Anas Younes, MD Louis S. Constine   +18 more
semanticscholar   +1 more source

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study [PDF]

, 2016
Background: Mantle-cell lymphoma is an aggressive B-cell lymphoma with a poor prognosis. Both ibrutinib and temsirolimus have shown single-agent activity in patients with relapsed or refractory mantle-cell lymphoma. We undertook a phase 3 study to assess
Balasubramanian, Sriram, Bandyopadhyay, Nibedita, Bence-Bruckler, Isabelle, Bothos, John, Caballero, Dolores, Cho, Seok-Goo, Dreyling, Martin, Enny, Christopher, Goldberg, Jenna D, Hess, Georg, Jerkeman, Mats, Joao, Cristina, Jurczak, Wojciech, Offner, Fritz, Rizo, Aleksandra, Rule, Simon, Rusconi, Chiara, Silva, Rodrigo Santucci, Sun, Steven, Traina, Shana, Trneny, Marek, Vermeulen, Jessica, Witzens-Harig, Mathias   +22 more
core   +1 more source

Burkitt's Lymphoma [PDF]

New England Journal of Medicine, 1977
TWO decades have passed since Denis Burkitt, a British surgeon working in Uganda, originally described the tumor that now bears his name.1 The discovery that this tumor has distinctive clinical and...
openaire   +7 more sources

Human leukocyte antigens and genetic susceptibility to lymphoma [PDF]

, 2015
Familial aggregation, coupled with ethnic variation in incidence, suggests that inherited susceptibility plays a role in the development of lymphoma, and the search for genetic risk factors has highlighted the contribution of the human leukocyte antigen (
Jarrett, R.F., McAulay, K.A.
core   +1 more source